Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/200286
Title: Targeting lymphoid-derived IL-17 signaling to delay skin aging
Author: Solá Castrillo, Paloma
Mereu, Elisabetta
Bonjoch, Júlia
Casado Peláez, Marta
Prats, Neus
Aguilera, Mònica
Reina, Oscar
Blanco, Enrique
Esteller, Manel
Croce, Luciano Di
Heyn, Holger
Solanas Fuster, Guiomar
Benitah, Salvador A.
Keywords: Immunitat
Pell
Envelliment
Immunity
Skin
Aging
Issue Date: 8-Jun-2023
Publisher: Springer Nature
Abstract: Skin aging is characterized by structural and functional changes that contribute to age-associated frailty. This probably depends on synergy between alterations in the local niche and stem cell-intrinsic changes, underscored by proinflammatory microenvironments that drive pleotropic changes. The nature of these age-associated inflammatory cues, or how they affect tissue aging, is unknown. Based on single-cell RNA sequencing of the dermal compartment of mouse skin, we show a skew towards an IL-17-expressing phenotype of T helper cells, γδ T cells and innate lymphoid cells in aged skin. Importantly, in vivo blockade of IL-17 signaling during aging reduces the proinflammatory state of the skin, delaying the appearance of age-related traits. Mechanistically, aberrant IL-17 signals through NF-κB in epidermal cells to impair homeostatic functions while promoting an inflammatory state. Our results indicate that aged skin shows signs of chronic inflammation and that increased IL-17 signaling could be targeted to prevent age-associated skin ailments.© 2023. The Author(s).
Note: Reproducció del document publicat a: https://doi.org/10.1038/s43587-023-00431-z
It is part of: Nature Aging, 2023, vol. 3, num. 6, p. 688-704
URI: http://hdl.handle.net/2445/200286
Related resource: https://doi.org/10.1038/s43587-023-00431-z
ISSN: 2662-8465
Appears in Collections:Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))

Files in This Item:
File Description SizeFormat 
Solà_Aznar_NatAging_2023.pdf9.27 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons